ARK Investment Management LLC 13D and 13G filings for Recursion Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 11:23 am Purchase |
2024-12-31 | 13G | Recursion Pharmaceuticals, Inc. RXRX |
ARK Investment Management LLC | 32,346,397 8.470% |
9,270,345 (+40.17%) |
Filing |
| 2024-02-12 12:21 pm Purchase |
2024-01-31 | 13G | Recursion Pharmaceuticals, Inc. RXRX |
ARK Investment Management LLC | 23,076,052 11.080% |
2,421,765 (+11.73%) |
Filing |
| 2024-01-29 4:00 pm Purchase |
2023-12-31 | 13G | Recursion Pharmaceuticals, Inc. RXRX |
ARK Investment Management LLC | 20,654,287 9.920% |
20,654,287 (New Position) |
Filing |